Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Roche to Ramp Up China Investment, Headcount

publication date: Sep 9, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Roche Holding AG will increase both its China investments and headcount, said Severin Schwan, CEO of the company, in an interview with The Wall Street Journal. Schwan was not specific about the dollar amount of its China commitment, but headcount will grow by 25% from its current base of 3,000. As we pointed out last week, the growth in China comes as Roche is cutting back its operations in Europe and the US.

Stock Symbol: (VS: ROG)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...